These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28207414)

  • 1. Anti-aging effects of M2000 (β-D-mannuronic acid) as a novel immunosuppressive drug on the enzymatic and non-enzymatic oxidative stress parameters in an experimental model.
    Hosseini S; Abdollahi M; Azizi G; Fattahi MJ; Rastkari N; Zavareh FT; Aghazadeh Z; Mirshafiey A
    J Basic Clin Physiol Pharmacol; 2017 May; 28(3):249-255. PubMed ID: 28207414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-aging property of G2013 molecule as a novel immunosuppressive agent on enzymatic and non-enzymatic oxidative stress determinants in Rat model.
    Mirshafiey A; Hosseini S; Afraei S; Rastkari N; Zavareh FT; Azizi G
    Curr Drug Discov Technol; 2016; 13(1):25-33. PubMed ID: 26906909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of β-D-Mannuronic Acid (M2000) on Oxidative Stress Enzymes' Gene Using Healthy Donor Peripheral Blood Mononuclear Cells for Evaluating the Anti-Aging Property.
    Taeb M; Jafarzadeh A; Mortazavi-Jahromi SS; Zainodini N; Mirzaei MR; Jafarnezhad-Ansariha F; Aghazadeh Z; Mirshafiey A
    Curr Drug Discov Technol; 2019; 16(3):265-271. PubMed ID: 29766814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of M2000 (D-Mannuronic Acid) on Learning, Memory Retrieval, and Associated Determinants in a Rat Model of Alzheimer's Disease.
    Athari Nik Azm S; Vafa M; Sharifzadeh M; Safa M; Barati A; Mirshafiey A
    Am J Alzheimers Dis Other Demen; 2017 Feb; 32(1):12-21. PubMed ID: 28100077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-diabetic effect of
    Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
    Arch Physiol Biochem; 2019 Dec; 125(5):435-440. PubMed ID: 29882437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
    Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
    Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenesis effect of β-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive properties under experimental model.
    Rastegari-Pouyani M; Mostafaie A; Mansouri K; Mortazavi-Jahromi SS; Mohammadi-Motlagh HR; Mirshafiey A
    Clin Exp Pharmacol Physiol; 2018 Apr; 45(4):370-376. PubMed ID: 29266560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on
    Barati A; Jamshidi AR; Ahmadi H; Aghazadeh Z; Mirshafiey A
    Drug Des Devel Ther; 2017; 11():1027-1033. PubMed ID: 28408801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.
    Jafarnezhad-Ansariha F; Yekaninejad MS; Jamshidi AR; Mansouri R; Vojdanian M; Mahmoudi M; Fattahi MJ; Hashemi SN; Rehm BHA; Matsuo H; Esposito E; Cuzzocrea S; Mirshafiey A
    Inflammopharmacology; 2018 Apr; 26(2):375-384. PubMed ID: 28819782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis.
    Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A
    Curr Drug Discov Technol; 2017; 14(3):206-214. PubMed ID: 28325148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property.
    Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Vojdanian M; Fattahi MJ; Rastkari N; Aghazadeh Z; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):433-442. PubMed ID: 29149783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of β-d-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1/COX-2 activity and gene expression.
    Mirshafiey A; Taeb M; Mortazavi-Jahromi SS; Jafarnezhad-Ansariha F; Rehm BHA; Esposito E; Cuzzocrea S; Matsuo H
    Pharmacol Rep; 2017 Oct; 69(5):1067-1072. PubMed ID: 28951072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of Sexual Hormones in Rheumatoid Arthritis Patients by M2000 (β-D-mannuronic Acid) as a Novel NSAID with Immunosuppressive Property.
    Jahanbakhshi M; Babaloo Z; Mortazavi-Jahromi SS; Shokri MM; Ahmadi H; Mirshafiey A
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):530-536. PubMed ID: 29667557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anti-Migraine Effects of M2000 (β-D-Mannuronic Acid) on a Patient with Rheumatoid Arthritis: Case Report.
    Vojdanian M; Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Barati A; Mirshafiey A
    Curr Clin Pharmacol; 2017; 12(2):127-130. PubMed ID: 28578645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-D-Mannuronic Acid (M2000) as a Landmark in Pharmacology.
    Gaafar NAG; Razavi A; Mirshafiey A
    Curr Drug Discov Technol; 2021; 18(1):47-57. PubMed ID: 31880246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis.
    Mirshafiey A; Matsuo H; Nakane S; Rehm BH; Koh CS; Miyoshi S
    Immunopharmacol Immunotoxicol; 2005; 27(2):255-65. PubMed ID: 16114509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Biology of β-D-mannuronic acid (M2000) on Human Dendritic Cell Based on MicroRNA-155 and MicroRNA-221.
    Tabrizian N; Fard NA; Farazmand A; Eftekhari R; Zavareh FT; Mirshafiey A
    Curr Drug Discov Technol; 2017; 14(1):53-58. PubMed ID: 27890012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions.
    Mortazavi-Jahromi SS; Jamshidi MM; Farazmand A; Aghazadeh Z; Yousefi M; Mirshafiey A
    Pharmacol Rep; 2017 Jun; 69(3):479-484. PubMed ID: 28324845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model.
    Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):284-289. PubMed ID: 29619884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritis.
    Mirshafiey A; Rehm B; Sotoude M; Razavi A; Abhari RS; Borzooy Z
    Immunopharmacol Immunotoxicol; 2007; 29(1):49-61. PubMed ID: 17464766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.